ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1627

Long Term Follow-Up of Patients with Childhood-Onset Lupus Nephritis After Transition to Adult Care

Dahima Cintrón1, Suheiry Márquez1 and Luis Vilá2, 1University of Puerto Rico Medical Sciences Campus, San Juan, PR, 2University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico

Meeting: ACR Convergence 2021

Keywords: Lupus nephritis, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Pediatric Rheumatology – Clinical Poster III: Miscellaneous Rheumatic Disease (1614–1644)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: Approximately 20% of patients with systemic lupus erythematosus (SLE) are diagnosed before 18 years of age. Pediatric patients have a worse disease course when compared to adults, and nearly 50% present with renal involvement. Most studies on childhood-onset lupus nephritis (cLN) are limited to the pediatric period. Therefore, we sought to determine the long term clinical outcomes in patients with cLN after reaching adulthood.

Methods: A cohort of Hispanics from Puerto Rico with SLE (per 1997 American College of Rheumatology classification criteria) was studied. Lupus nephritis (LN) was defined as the presence of proteinuria >0.5 g per day, urinary cellular casts, and/or a renal biopsy consistent with LN. Demographic parameters, clinical manifestations, comorbidities, disease activity (per Systemic Lupus Erythematosus Disease Activity Index ([SLEDAI]), disease damage (per Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index [SDI]), pharmacologic therapy, renal response, and chronic kidney disease staging (per National Kidney Foundation) were gathered at LN onset (baseline) and at last visit. Data from patients with cLN were compared to those with adult-onset LN (aLN) using Chi-square test, Fisher’s exact test, or Mann-Whitney test, as appropriate.

Results: In total, 142 SLE patients with LN were studied; 27 (19%) had cLN and 115 (81%) had aLN. Among cLN patients, 88% were female. The mean (standard deviation [SD]) age at SLE diagnosis and LN onset for cLN patients were 14.6 (3.2) and 16.1 (3.9) years, respectively. The mean (SD) LN duration and follow-up after reaching adulthood were 14.7 (7.8) and 13.4 (7.7) years, respectively. No significant differences were found at baseline and last visit for lupus manifestations, comorbidities, SLEDAI and SDI scores, and pharmacologic treatment (induction and maintenance therapeutic modalities) between patients with cLN and aLN. Renal outcomes are depicted in table1. No significant differences were found for renal outcomes between these groups.

Conclusion: In this cohort of Puerto Ricans with SLE, patients with cLN followed through adulthood for more than a decade had a favorable outcome. Most patients remained in chronic kidney disease stage 1 or 2 and few evolved into end-stage-renal disease. Furthermore, long term renal outcomes were similar to those with aLN. The results of this study differ from those from other ethnic populations that show poor clinical outcomes in patients with cLN.


Disclosures: D. Cintrón, None; S. Márquez, None; L. Vilá, None.

To cite this abstract in AMA style:

Cintrón D, Márquez S, Vilá L. Long Term Follow-Up of Patients with Childhood-Onset Lupus Nephritis After Transition to Adult Care [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/long-term-follow-up-of-patients-with-childhood-onset-lupus-nephritis-after-transition-to-adult-care/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/long-term-follow-up-of-patients-with-childhood-onset-lupus-nephritis-after-transition-to-adult-care/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology